Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125225921 | 12522592 | 1 | I | 2015 | 20160616 | 20160701 | 20160701 | EXP | CA-HQ SPECIALTY-CA-2016INT000425 | INTERCHEM | 39.00 | YR | F | Y | 0.00000 | 20160701 | CN | CA | CA |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125225921 | 12522592 | 1 | PS | METHOTREXATE SODIUM. | METHOTREXATE SODIUM | 1 | Oral | 3.5714 MG (25 MG, 1 IN 1 W) | Y | 201749 | 25 | MG | |||||||
| 125225921 | 12522592 | 2 | SS | METHOTREXATE SODIUM. | METHOTREXATE SODIUM | 1 | Oral | 0.8571 MG (6 MG, 1 IN 1 W) | Y | 201749 | 6 | MG | |||||||
| 125225921 | 12522592 | 3 | SS | PLAQUENIL /00072602/ | HYDROXYCHLOROQUINE DIPHOSPHATE | 1 | 400 MG (200 MG, 2 IN 1 D) | 0 | 200 | MG | |||||||||
| 125225921 | 12522592 | 4 | SS | SULFASALAZINE. | SULFASALAZINE | 1 | 2 G | 0 | 2 | G | |||||||||
| 125225921 | 12522592 | 5 | SS | XELJANZ | TOFACITINIB CITRATE | 1 | Oral | 10 MG (5 MG, 2 IN 1 D) | 0 | 5 | MG | ||||||||
| 125225921 | 12522592 | 6 | C | FOLIC ACID. | FOLIC ACID | 1 | UNK | U | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125225921 | 12522592 | 1 | Rheumatoid arthritis |
| 125225921 | 12522592 | 3 | Rheumatoid arthritis |
| 125225921 | 12522592 | 4 | Rheumatoid arthritis |
| 125225921 | 12522592 | 5 | Rheumatoid arthritis |
| 125225921 | 12522592 | 6 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125225921 | 12522592 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125225921 | 12522592 | Drug ineffective | |
| 125225921 | 12522592 | Drug intolerance | |
| 125225921 | 12522592 | Eye discharge | |
| 125225921 | 12522592 | Fatigue | |
| 125225921 | 12522592 | Headache | |
| 125225921 | 12522592 | Nasopharyngitis | |
| 125225921 | 12522592 | Nausea | |
| 125225921 | 12522592 | Oropharyngeal pain | |
| 125225921 | 12522592 | Rhinorrhoea | |
| 125225921 | 12522592 | Sinus pain |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 125225921 | 12522592 | 1 | 20150204 | 0 | ||
| 125225921 | 12522592 | 3 | 20150204 | 0 | ||
| 125225921 | 12522592 | 4 | 20150204 | 0 | ||
| 125225921 | 12522592 | 5 | 20160126 | 0 |